Literature DB >> 18563617

Prevalence of the overactive bladder among Iranian women based on the International Continence Society definition: a population-based study.

Mohammad Reza Safarinejad1.   

Abstract

There is a continuing debate on the accurate prevalence estimates of overactive bladder (OAB) among different ethnicities and regions. The aims of our study were to determine the prevalence of OAB, associated risk factors, and the impact of OAB on the quality of life and sexual function of Iranian women. A total of 8748 women between 15 and 55 years of age enrolled in this cross-sectional study. The definition of the 2002 International Continence Society (ICS) was applied to assess the prevalence of OAB. All participants underwent a detailed history and physical examination that included an evaluation of quality of life, coping strategies and treatment-seeking behavior, laboratory tests, urinalysis and current or previous therapy. The degree of bother was quantified using s visual analog scale (VAS). The overall prevalence of OAB was found to be 18.2% and increased with age from 10.9% in adults aged 15-29 years to 26.2% in those aged >50 years old (test for trend, P = 0.001). A negative impact of OAB on sexual function was reported by 72.3% of the women. Frequency was the most commonly reported symptom (67% of women), followed by urgency (54%). Subjects with OAB had a higher prevalence of anxiety (28.2 vs. 8.8%; P = 0.001), depression (38.2 vs. 18.2%; P = 0.02) and tiredness (16.4 vs. 2.7%; P = 0.001), and they reported significant impairment in carrying out household chores (P = 0.01), physical activities (P = 0.01) and work-related activities (P = 0.01) as well as negative effects on education (P = 0.02), sleep (P = 0.001), relationships (P = 0.001) and annual income (P = 0.01). The prevalence of OAB in Iranian women is higher than that reported in many previous studies in developed and developing countries. Our results reveal that OAB is a highly prevalent condition among Iranian women and that is has a serious impact on quality of life and sexual function.

Entities:  

Mesh:

Year:  2008        PMID: 18563617     DOI: 10.1007/s11255-008-9403-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

1.  Overactive bladder: defining the disease.

Authors:  A J Wein
Journal:  Am J Manag Care       Date:  2000-07       Impact factor: 2.229

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

3.  Health-related consequences of overactive bladder: an economic perspective.

Authors:  Teh-Wei Hu; Todd H Wagner
Journal:  BJU Int       Date:  2005-09       Impact factor: 5.588

4.  How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.

Authors:  I Milsom; P Abrams; L Cardozo; R G Roberts; J Thüroff; A J Wein
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

5.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

6.  The epidemiology of overactive bladder among females in Asia: a questionnaire survey.

Authors:  M C Lapitan; P L Chye
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

7.  The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing.

Authors:  S Jackson; J Donovan; S Brookes; S Eckford; L Swithinbank; P Abrams
Journal:  Br J Urol       Date:  1996-06

8.  Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women.

Authors:  Gin-Den Chen; Tzu-Li Lin; Suh-Woan Hu; Yi-Ching Chen; Long-Yau Lin
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

9.  Overactive bladder: prevalence and implications in Brazil.

Authors:  Claudio Teloken; Fernanda Caraver; Fernanda A Weber; Patrick E Teloken; João F Moraes; Paulo R Sogari; Túlio M Graziottin
Journal:  Eur Urol       Date:  2006-02-09       Impact factor: 20.096

10.  Prevalence and burden of overactive bladder in the United States.

Authors:  W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal:  World J Urol       Date:  2002-11-15       Impact factor: 4.226

View more
  3 in total

1.  Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.

Authors:  Prashanth Kanagarajah; Rajinikanth Ayyathurai; Daniel J Caruso; Christopher Gomez; Angelo E Gousse
Journal:  Int Urol Nephrol       Date:  2011-06-04       Impact factor: 2.370

2.  Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial.

Authors:  Bulent Cetinel; Bulent Onal; Mehmet Hamza Gultekin; Muhammed Guzelsoy; Fethi Ahmet Turegun; Murat Dincer
Journal:  Int Urol Nephrol       Date:  2019-02-06       Impact factor: 2.370

3.  The hidden epidemic of urinary incontinence in women: a population-based study with emphasis on preventive strategies.

Authors:  Batoul Ahmadi; Masoumeh Alimohammadian; Banafsheh Golestan; Bahar Mahjubi; Leila Janani; Rezvan Mirzaei
Journal:  Int Urogynecol J       Date:  2010-01-20       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.